Wright Buys French Extremities Device Firm For $75 Million Upfront
This article was originally published in The Gray Sheet
The acquisition of Biotech International is intended to provide Wright with a complementary extremity product portfolio and to significantly expand Wright’s direct sales channel in France and international distribution network for foot and ankle products.
You may also be interested in...
Given Imaging, soon to be part of Covidien, gained clearance for PillCam Colon capsule endoscopy device. FDA approves its first continuous glucose monitoring system for kids. Congress makes progress in the sustainable growth rate formula bill. More news.
News Briefs: FDA Turns Down Wright’s Augment; Cook Resumes Zilver PTX Shipments; Luminex Restructures
Wright Medical receives not approvable letter for its Augment bone graft asking for another study. Judge rules against Zimmer in favor of Strkyer in patent case. Cook Medical has resolved the problems that triggered a December 2012 recall of its Zilver PTX peripheral stent. Luminex cuts staff, invests in molecular diagnostics efforts.
Wright, by selling its hip-and-knee reconstruction business, is abandoning the stagnant U.S. large-joint sector, choosing instead to tie its future to the faster growing extremities market. Shanghai-based MicroPort, meanwhile, is looking to compete in China’s growing large-joint market.